Machina Capital S.A.S. Regeneron Pharmaceuticals, Inc. Transaction History

Machina Capital S.A.S.

$238 Million
Q3 2024

A detailed history of Machina Capital S.A.S. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Machina Capital S.A.S. holds 517 shares of REGN stock, worth $390,267. This represents 0.23% of its overall portfolio holdings.

Number of Shares

517

Previous 333 55.26%

Holding current value

$390,267

Previous $349,000 55.59%

% of portfolio

0.23%

Previous 0.16%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$1024.09 - $1201.76 $188,432 - $221,123	184 Added 55.26%	517 $543,000
Q2 2024 Aug 09, 2024	SELL	$883.2 - $1071.19 $860,236 - $1.04 Million	-974 Reduced 74.52%	333 $349,000
Q1 2024 May 13, 2024	SELL	$902.69 - $993.35 $274,417 - $301,978	-304 Reduced 18.87%	1,307 $1.26 Million
Q4 2023 Feb 06, 2024	BUY	$775.18 - $881.7 $689,135 - $783,831	889 Added 123.13%	1,611 $1.41 Million
Q3 2023 Nov 02, 2023	BUY	$692.45 - $844.37 $499,948 - $609,635	722 New	722 $594,000
Q1 2023 Apr 24, 2023	BUY	$680.49 - $826.97 $415,779 - $505,278	611 New	611 $502,000
Q3 2022 Nov 10, 2022	SELL	$573.97 - $724.32 $289,280 - $365,057	-504 Reduced 48.46%	536 $369,000
Q2 2022 Aug 08, 2022	BUY	$548.35 - $738.84 $570,284 - $768,393	1,040 New	1,040 $615,000
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $216,069 - $255,252	-457 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $204,155 - $250,527	457 New	457 $216,000
Q4 2019 Feb 07, 2020	SELL	$274.13 - $376.51 $473,148 - $649,856	-1,726 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$273.46 - $318.39 $522,035 - $607,806	-1,909 Reduced 52.52%	1,726 $479,000
Q2 2019 Jul 19, 2019	BUY	$299.6 - $414.82 $884,718 - $1.22 Million	2,953 Added 432.99%	3,635 $1.14 Million
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $253,758 - $299,786	682 New	682 $280,000

Others Institutions Holding REGN

# of Institutions

1,532

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $80.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Machina Capital S.A.S., based on Form 13F filings with the SEC.

News

Stay updated on Machina Capital S.A.S. with notifications on news.

Account

Machina Capital S.A.S. Regeneron Pharmaceuticals, Inc. Transaction History